Viewing Study NCT05478993


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2025-12-25 @ 11:25 PM
Study NCT ID: NCT05478993
Status: RECRUITING
Last Update Posted: 2024-01-31
First Post: 2022-07-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement
Sponsor: Peking University People's Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2024-07-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-07-10
Completion Date Type: ESTIMATED
First Submit Date: 2022-07-24
First Submit QC Date: None
Study First Post Date: 2022-07-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-30
Last Update Post Date: 2024-01-31
Last Update Post Date Type: ACTUAL